Seiji Yano
professor
Oncology
NUS
Singapore
Biography
Dr. Yano is translational thoracic medical oncologist and a Professor at Cancer Research Institute, Kanazawa University, Japan. He is also a director of Kanazawa University Cancer Center. He earned his MD and PhD from the School of Medicine at University of Tokushima, Japan. In 2009, he earned Diplomate, Subspecialty Board of Medical Oncology, Japanese Society of Medical Oncology (JSMO). He has been a member of IASLC since 2011. Dr. Yano’s research combines laboratory based studies, with translational research and clinical trials of molecular targeted therapy in lung cancer patients. His main research interest is the understanding molecular mechanisms of resistance to targeted therapy and developing novel therapeutics to treat the resistance in lung cancer. He discovered HGFtriggered resistance as a novel resistance mechanism to EGFR-TKI in EGFR mutant lung cancer. Dr Yano has received several awards for his research including 2013 JCA Mauvernay Award from Japanese Cancer Association and 2010 Shinoi-Kawai Award from Japan Lung Cancer Society
Research Interest
understanding molecular mechanisms of resistance to targeted therapy and developing novel therapeutics to treat the resistance in lung cancer.
